Cargando…

Traditional Classification and Novel Subtyping Systems for Bladder Cancer

Bladder cancer is the most common tumor in the urinary system, with approximately 420,000 new cases and 160,000 deaths per year. The European Organization for Research and Treatment of Cancer (EOTRC) classifies non-muscular invasive bladder cancer (NMIBC) into low-risk, medium-risk and high-risk gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Shaoming, Yu, Weimin, Yang, Xiao, Wu, Cheng, Cheng, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025453/ https://www.ncbi.nlm.nih.gov/pubmed/32117752 http://dx.doi.org/10.3389/fonc.2020.00102

Ejemplares similares

Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer
por: Chen, Kang, et al.
Publicado: (2022)

Corrigendum: Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer
por: Chen, Kang, et al.
Publicado: (2022)

Identification of endothelial-related molecular subtypes for bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression
por: Xia, Yuqi, et al.
Publicado: (2021)

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays
por: Chen, Kang, et al.
Publicado: (2021)

Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment
por: Song, Tianbao, et al.
Publicado: (2022)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Novel Combination Therapies for the Treatment of Bladder Cancer
por: Peng, Mei, et al.
Publicado: (2021)

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
por: Yu, Xi, et al.
Publicado: (2021)

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
por: Blanca, Ana, et al.
Publicado: (2023)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
por: Tang, Chaozhi, et al.
Publicado: (2020)

Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers
por: Wang, Zhen-zhen, et al.
Publicado: (2023)

M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer
por: Zhu, Huili, et al.
Publicado: (2021)

Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
por: Wu, Zixuan, et al.
Publicado: (2023)

Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022)

SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway
por: Chen, Wu, et al.
Publicado: (2021)

Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer
por: Xie, Tianwen, et al.
Publicado: (2019)

Robust Prognostic Subtyping of Muscle-Invasive Bladder Cancer Revealed by Deep Learning-Based Multi-Omics Data Integration
por: Zhang, Xiaolong, et al.
Publicado: (2021)

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes
por: Liu, Yi, et al.
Publicado: (2021)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
por: Chen, Shuangfeng, et al.
Publicado: (2021)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Quantitative Multiparametric MRI as an Imaging Biomarker for the Prediction of Breast Cancer Receptor Status and Molecular Subtypes
por: Yang, Zhiqi, et al.
Publicado: (2021)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Machine Learning for Histologic Subtype Classification of Non-Small Cell Lung Cancer: A Retrospective Multicenter Radiomics Study
por: Yang, Fengchang, et al.
Publicado: (2021)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Multimodal Dimension Reduction and Subtype Classification of Head and Neck Squamous Cell Tumors
por: Bard, Jonathan E., et al.
Publicado: (2022)

A multilayer perceptron-based model applied to histopathology image classification of lung adenocarcinoma subtypes
por: Liu, Mingyang, et al.
Publicado: (2023)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia
por: Xiao, Yu, et al.
Publicado: (2022)

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis
por: Li, Qin, et al.
Publicado: (2018)

Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes
por: Chen, Qi, et al.
Publicado: (2023)

A Transcription Factor Signature Can Identify the CMS4 Subtype and Stratify the Prognostic Risk of Colorectal Cancer
por: Zhong, Min-Er, et al.
Publicado: (2022)

Identification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment
por: Shen, Rongfang, et al.
Publicado: (2020)

Identifying novel biomarkers associated with bladder cancer treatment outcomes
por: Castaneda, Peris R., et al.
Publicado: (2023)

Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features
por: Font, Albert, et al.
Publicado: (2023)

A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
por: Yang, Libo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k0pb7o2kgrsthcg7uledss4d9p